Zions Bancorporation, National Association’s ADMA Biologics ADMA Stock Holding History

Zions Bancorporation, National Association’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Sell	36,247 -7,900	-18%	-$72K	0.02%	324
2026 Q1	$398K	Sell	44,147 -24,863	-36%	-$392K	0.03%	276
2025 Q4	$1.26M	Sell	69,010 -4,852	-7%	-$81.8K	0.06%	212
2025 Q3	$1.08M	Buy	73,862 +20,045	+37%	+$344K	0.05%	215
2025 Q2	$980K	Buy	+53,817	New	+$1.1M	0.05%	223

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Zions Bancorporation, National Association's ADMA Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its ADMA Biologics (ADMA) stake by 18% in Q2 2026, selling an estimated $72K and leaving 36,247 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #324.

Zions Bancorporation, National Association first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.26M in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Zions Bancorporation, National Association held 36,247 shares of ADMA Biologics worth $303K as of Q2 2026.
Zions Bancorporation, National Association sold 7,900 ADMA Biologics shares in Q2 2026, an estimated $72K.
ADMA Biologics made up 0.02% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #324 holding.
Zions Bancorporation, National Association first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
Zions Bancorporation, National Association's ADMA Biologics position peaked at $1.26M in Q4 2025.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.